MDA5 autoantibody-another indicator of clinical diversity in dermatomyositis.


Allenbach and colleagues have recently reported for the first time the results of an intriguing study of the histopathologic, immunopathologic and gene expression differences in muscle biopsy tissue from adult dermatomyositis (DM) patients who do and do not have circulating MDA5 autoantibodies (anti-MDA5). Anti-MDA5 were originally identified in a… (More)
DOI: 10.21037/atm.2017.03.94